Every year in the United States, millions of MRI (magnetic resonance imaging) scans are performed to diagnose a wide variety of injuries and diseases. The images provided have helped saved countless people whose afflictions would not have been identifiable otherwise.
However, more patients are claiming gadolinium-based contrast agents are putting patients at risk of potentially deadly side effects. The substance injected before MRIs may affect the kidneys and result in a condition known as nephrogenic systemic fibrosis (NSF). Some have reported side effects to other organs as well.
As a result of the rise in complications, hundreds of patients have filed lawsuits against the makers of gadolinium-based contrast agents over allegations that they failed to warn the public about their risks.